EHR Use More Than Doubles

Share this content:
EHR Use More Than Doubles
EHR Use More Than Doubles

(HealthDay News) -- Almost 80% of doctors in the United States have switched from paper to electronic health records (EHRs), new government statistics show.

By 2012, almost 72% of physicians had made the change, compared to just under 35% in 2007, according to the report from the U.S. Centers for Disease Control and Prevention. Since then, the number of doctors using EHRs has increased even more, lead researcher Esther Hing, a statistician at the CDC's U.S. National Center for Health Statistics, told HealthDay

RELATED: Have You Seen Electronic Health Records Lately?

"In 2013, 78% of physicians were using electronic health record systems," she said. "We are reaching nearly all the doctors."

Of the doctors who turned to EHRs by 2012, 39.6% used a basic system, up from 11.8% in 2007, the researchers found. And 23.5% had a fully functional system, up from 3.8% in 2007. Hing noted that the progress is largely the result of the federal government's financial incentives to help doctors change to electronic recordkeeping.

"These incentives have had a large part in the increased adoption of these systems," Hing said. 

However, many doctors (about 40%) aren't using the full capabilities of their system, Hing noted. Once the system is installed, there is a steep learning curve before doctors and other staff are able to use it efficiently, she said.

To read the full article, click here

.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs